Dr. Angel Qin is a Clinical Assistant Professor at the University of Michigan Rogel Cancer Center.  Her research interests include mechanisms of resistance to treatment and targeted therapies. She is the clinical lead of the Judy Tam ALK NSCLC Research Initiative, focusing on ALK positive NSCLC that have become resistant to TKIs. She is an active clinical investigator with multiple investigator-initiated trials and participates in cooperative group and industry-sponsored trials. She is a member of the SWOG Lung Committee, NCCN Small Cell Lung Cancer Committee, and the IASLC Multidisciplinary Clinical Science Committee. She is the co-chair of the Thoracic Oncology Clinical Research Team at the University of Michigan.